Blogs
April 20, 2026
The CFO/PAT ratio is the single fastest earnings-quality check any Indian value investor can run — and Titan Biotech FY25 audited numbers show what disciplined cash-backed profits actually look like.
April 20, 2026
Tversky & Kahneman's 1973 availability heuristic explains why Indian retail investors chase recent headlines. A detailed teaching post with an illustrative Titan Biotech FY25 case study on availability-resistant corporate behaviour.
April 20, 2026
Why serious investors should read segment notes to discover where the real business quality sits, and how Titan’s geographic split strengthens trust in the disclosure.
April 20, 2026
Warren Buffett's 1986 owner-earnings formula adjusts reported net profit by adding back non-cash charges and subtracting maintenance capex and working-capital needs. Applied to four Indian businesses — Asian Paints, Pidilite, Nestlé India, and Titan Biotech — the arithmetic reveals very different cash-conversion profiles and gives retail investors a more honest lens than reported PAT alone.
